Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02POV
|
||||
| Former ID |
DNC012315
|
||||
| Drug Name |
1-(2-Phenyl-propyl)-3-thiazol-2-yl-thiourea
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H15N3S2
|
||||
| Canonical SMILES |
CC(CNC(=S)NC1=NC=CS1)C2=CC=CC=C2
|
||||
| InChI |
1S/C13H15N3S2/c1-10(11-5-3-2-4-6-11)9-15-12(17)16-13-14-7-8-18-13/h2-8,10H,9H2,1H3,(H2,14,15,16,17)
|
||||
| InChIKey |
NQIQJPRBRMXGMW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV-1 reverse transcriptase | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.